• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溶酶体神经酰胺代谢紊乱:对帕金森病的影响。

Lysosomal Ceramide Metabolism Disorders: Implications in Parkinson's Disease.

作者信息

Paciotti Silvia, Albi Elisabetta, Parnetti Lucilla, Beccari Tommaso

机构信息

Laboratory of Clinical Neurochemistry, Department of Medicine, University of Perugia, Sant'Andrea delle Fratte, 06132 Perugia, Italy.

Section of Physiology and Biochemistry, Department of Experimental Medicine, University of Perugia, Sant'Andrea delle Fratte, 06132 Perugia, Italy.

出版信息

J Clin Med. 2020 Feb 21;9(2):594. doi: 10.3390/jcm9020594.

DOI:10.3390/jcm9020594
PMID:32098196
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7073989/
Abstract

Ceramides are a family of bioactive lipids belonging to the class of sphingolipids. Sphingolipidoses are a group of inherited genetic diseases characterized by the unmetabolized sphingolipids and the consequent reduction of ceramide pool in lysosomes. Sphingolipidoses include several disorders as Sandhoff disease, Fabry disease, Gaucher disease, metachromatic leukodystrophy, Krabbe disease, Niemann Pick disease, Farber disease, and GM2 gangliosidosis. In sphingolipidosis, lysosomal lipid storage occurs in both the central nervous system and visceral tissues, and central nervous system pathology is a common hallmark for all of them. Parkinson's disease, the most common neurodegenerative movement disorder, is characterized by the accumulation and aggregation of misfolded α-synuclein that seem associated to some lysosomal disorders, in particular Gaucher disease. This review provides evidence into the role of ceramide metabolism in the pathophysiology of lysosomes, highlighting the more recent findings on its involvement in Parkinson's disease.

摘要

神经酰胺是一类属于鞘脂类的生物活性脂质。鞘脂贮积症是一组遗传性疾病,其特征是鞘脂代谢异常,导致溶酶体中神经酰胺池减少。鞘脂贮积症包括多种疾病,如桑德霍夫病、法布里病、戈谢病、异染性脑白质营养不良、克拉贝病、尼曼-匹克病、法伯病和GM2神经节苷脂沉积症。在鞘脂贮积症中,溶酶体脂质蓄积发生在中枢神经系统和内脏组织中,中枢神经系统病变是所有这些疾病的共同特征。帕金森病是最常见的神经退行性运动障碍,其特征是错误折叠的α-突触核蛋白的积累和聚集,这似乎与某些溶酶体疾病有关,特别是戈谢病。本综述提供了神经酰胺代谢在溶酶体病理生理学中作用的证据,突出了其与帕金森病关系的最新研究结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31eb/7073989/263feca4b829/jcm-09-00594-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31eb/7073989/c43ccfe1039d/jcm-09-00594-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31eb/7073989/735f568d7392/jcm-09-00594-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31eb/7073989/263feca4b829/jcm-09-00594-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31eb/7073989/c43ccfe1039d/jcm-09-00594-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31eb/7073989/735f568d7392/jcm-09-00594-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31eb/7073989/263feca4b829/jcm-09-00594-g003.jpg

相似文献

1
Lysosomal Ceramide Metabolism Disorders: Implications in Parkinson's Disease.溶酶体神经酰胺代谢紊乱:对帕金森病的影响。
J Clin Med. 2020 Feb 21;9(2):594. doi: 10.3390/jcm9020594.
2
Gene Therapy of Sphingolipid Metabolic Disorders.鞘脂代谢障碍的基因治疗。
Int J Mol Sci. 2023 Feb 11;24(4):3627. doi: 10.3390/ijms24043627.
3
The Link between Gaucher Disease and Parkinson's Disease Sheds Light on Old and Novel Disorders of Sphingolipid Metabolism.戈谢病与帕金森病之间的关联为鞘脂代谢的旧疾与新疾提供了新的认识。
Int J Mol Sci. 2019 Jul 5;20(13):3304. doi: 10.3390/ijms20133304.
4
Lysosomal storage diseases.溶酶体贮积症
Transl Sci Rare Dis. 2017 May 25;2(1-2):1-71. doi: 10.3233/TRD-160005.
5
Lipid storage disease: Part II. Ultrastructural pathology of lipid storage cells in sphingolipidoses.脂质贮积病:第二部分。鞘脂类沉积症中脂质贮积细胞的超微结构病理学。
Acta Pathol Jpn. 1985 Mar;35(2):385-408.
6
Rare Diseases in Glycosphingolipid Metabolism.糖脂代谢相关罕见病
Adv Exp Med Biol. 2022;1372:189-213. doi: 10.1007/978-981-19-0394-6_13.
7
The sphiningolipidoses: an overview.鞘脂类贮积病:概述
Postgrad Med. 1977 Mar;61(3):90-3, 95. doi: 10.1080/00325481.1977.11712151.
8
From sheep to mice to cells: tools for the study of the sphingolipidoses.从绵羊到小鼠再到细胞:鞘脂类疾病的研究工具
Biochim Biophys Acta. 2014 Aug;1841(8):1189-99. doi: 10.1016/j.bbalip.2014.02.008. Epub 2014 Mar 4.
9
Lysosomal Glycosphingolipid Storage Diseases.溶酶体糖脂贮积症。
Annu Rev Biochem. 2019 Jun 20;88:461-485. doi: 10.1146/annurev-biochem-013118-111518.
10
Altered Sphingolipid Hydrolase Activities and Alpha-Synuclein Level in Late-Onset Schizophrenia.迟发性精神分裂症中鞘脂水解酶活性及α-突触核蛋白水平的改变
Metabolites. 2023 Dec 31;14(1):30. doi: 10.3390/metabo14010030.

引用本文的文献

1
Sphingomyelin regulates the transcriptional machinery in nuclear lipid microdomains.鞘磷脂调节核脂质微区中的转录机制。
Commun Biol. 2025 Aug 29;8(1):1303. doi: 10.1038/s42003-025-08697-2.
2
Lipid metabolism in health and disease: Mechanistic and therapeutic insights for Parkinson's disease.健康与疾病中的脂质代谢:帕金森病的机制与治疗见解
Chin Med J (Engl). 2025 Jun 20;138(12):1411-1423. doi: 10.1097/CM9.0000000000003627. Epub 2025 May 26.
3
Peripheral Upregulation of Parkinson's Disease-Associated Genes Encoding α-Synuclein, β-Glucocerebrosidase, and Ceramide Glucosyltransferase in Major Depression.

本文引用的文献

1
Ambroxol for the Treatment of Patients With Parkinson Disease With and Without Glucocerebrosidase Gene Mutations: A Nonrandomized, Noncontrolled Trial.氨溴索治疗伴有和不伴有葡萄糖脑苷脂酶基因突变的帕金森病患者:一项非随机、非对照试验。
JAMA Neurol. 2020 Apr 1;77(4):427-434. doi: 10.1001/jamaneurol.2019.4611.
2
The Acid Sphingomyelinase/ Ceramide System as Target for Ischemic Stroke Therapies.酸性鞘磷脂酶/神经酰胺系统作为缺血性中风治疗的靶点
Neurosignals. 2019;27(S1):32-43. doi: 10.33594/000000184.
3
Pharmacological Inhibition of Acid Sphingomyelinase Ameliorates Experimental Autoimmune Encephalomyelitis.
外周上调帕金森病相关基因编码的 α-突触核蛋白、β-葡糖苷脑苷脂酶和神经酰胺葡萄糖基转移酶在重度抑郁症中的表达。
Int J Mol Sci. 2024 Mar 12;25(6):3219. doi: 10.3390/ijms25063219.
4
Common genetic risk for Parkinson's disease and dysfunction of the endo-lysosomal system.帕金森病的常见遗传风险与内溶酶体系统功能障碍。
Philos Trans R Soc Lond B Biol Sci. 2024 Apr 8;379(1899):20220517. doi: 10.1098/rstb.2022.0517. Epub 2024 Feb 19.
5
Altered Sphingolipid Hydrolase Activities and Alpha-Synuclein Level in Late-Onset Schizophrenia.迟发性精神分裂症中鞘脂水解酶活性及α-突触核蛋白水平的改变
Metabolites. 2023 Dec 31;14(1):30. doi: 10.3390/metabo14010030.
6
4-Methylumbelliferone Targets Revealed by Public Data Analysis and Liver Transcriptome Sequencing.4-甲基伞形酮通过公共数据分析和肝转录组测序揭示的靶点。
Int J Mol Sci. 2023 Jan 21;24(3):2129. doi: 10.3390/ijms24032129.
7
Age-Related Decline in Gangliosides GM1 and GD1a in Non-CNS Tissues of Normal Mice: Implications for Peripheral Symptoms of Parkinson's Disease.正常小鼠非中枢神经系统组织中神经节苷脂GM1和GD1a随年龄的下降:对帕金森病外周症状的影响
Biomedicines. 2023 Jan 14;11(1):209. doi: 10.3390/biomedicines11010209.
8
Role of Ceramides and Lysosomes in Extracellular Vesicle Biogenesis, Cargo Sorting and Release.神经酰胺和溶酶体在细胞外囊泡生物发生、货物分选和释放中的作用。
Int J Mol Sci. 2022 Dec 5;23(23):15317. doi: 10.3390/ijms232315317.
9
Galactosylceramidase deficiency and pathological abnormalities in cerebral white matter of Krabbe disease.半乳糖脑苷脂酶缺乏症和脑白质病变的克雅氏病。
Neurobiol Dis. 2022 Nov;174:105862. doi: 10.1016/j.nbd.2022.105862. Epub 2022 Sep 14.
10
The role of NURR1 in metabolic abnormalities of Parkinson's disease.NURR1 在帕金森病代谢异常中的作用。
Mol Neurodegener. 2022 Jun 27;17(1):46. doi: 10.1186/s13024-022-00544-w.
酸性鞘磷脂酶的药理学抑制改善实验性自身免疫性脑脊髓炎。
Neurosignals. 2019;27(S1):20-31. doi: 10.33594/000000183.
4
The vicious cycle between α-synuclein aggregation and autophagic-lysosomal dysfunction.α-突触核蛋白聚集与自噬溶酶体功能障碍之间的恶性循环。
Mov Disord. 2020 Jan;35(1):34-44. doi: 10.1002/mds.27895. Epub 2019 Nov 15.
5
Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson's disease.帕金森病中鞘脂类水解酶活性、底物堆积和神经节苷脂水平降低。
Mol Neurodegener. 2019 Nov 8;14(1):40. doi: 10.1186/s13024-019-0339-z.
6
Revisiting the non-Gaucher-GBA-E326K carrier state: Is it sufficient to increase Parkinson's disease risk?重新审视非 Gaucher-GBA-E326K 携带者状态:是否足以增加帕金森病风险?
Mol Genet Metab. 2019 Dec;128(4):470-475. doi: 10.1016/j.ymgme.2019.10.001. Epub 2019 Oct 13.
7
Glucocerebrosidase activity, cathepsin D and monomeric α-synuclein interactions in a stem cell derived neuronal model of a PD associated GBA1 mutation.帕金森病相关 GBA1 突变的干细胞衍生神经元模型中葡萄糖脑苷脂酶活性、组织蛋白酶 D 和单体α-突触核蛋白相互作用。
Neurobiol Dis. 2020 Feb;134:104620. doi: 10.1016/j.nbd.2019.104620. Epub 2019 Oct 18.
8
Progress in the understanding and treatment of Fabry disease.法布瑞氏病的研究进展与治疗。
Biochim Biophys Acta Gen Subj. 2020 Jan;1864(1):129437. doi: 10.1016/j.bbagen.2019.129437. Epub 2019 Sep 14.
9
Gentamicin Targets Acid Sphingomyelinase in Cancer: The Case of the Human Gastric Cancer NCI-N87 Cells.庆大霉素靶向酸性鞘磷脂酶在癌症中的作用:以人胃癌 NCI-N87 细胞为例。
Int J Mol Sci. 2019 Sep 6;20(18):4375. doi: 10.3390/ijms20184375.
10
Arylsulfatase A, a genetic modifier of Parkinson's disease, is an α-synuclein chaperone.芳香基硫酸酯酶 A,帕金森病的遗传修饰因子,是一种α-突触核蛋白伴侣。
Brain. 2019 Sep 1;142(9):2845-2859. doi: 10.1093/brain/awz205.